Theratechnologies Azioni in circolazione
Cos'è Azioni in circolazione di Theratechnologies?
Azioni in circolazione di Theratechnologies, Inc. è 95.142M
Qual è la definizione di Azioni in circolazione?
Le azioni in circolazione sono tutte le azioni di una società o di un'attività finanziaria che sono state autorizzate, emesse e acquistate dagli investitori e sono detenute da loro.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Azioni in circolazione di aziende nel Health Care settore su TSX rispetto a Theratechnologies
Cosa fa Theratechnologies?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Aziende con azioni in circolazione simili a Theratechnologies
- Shriro ha Azioni in circolazione di 95.088M
- Lilis ha Azioni in circolazione di 95.098M
- Western Asset High Income Opportunity Fund Inc ha Azioni in circolazione di 95.099M
- Monadelphous ha Azioni in circolazione di 95.122M
- Silver Viper Minerals ha Azioni in circolazione di 95.130M
- Beijing Chunlizhengda Medical Instruments Co ha Azioni in circolazione di 95.140M
- Theratechnologies ha Azioni in circolazione di 95.142M
- GasLog Ltd ha Azioni in circolazione di 95.193M
- Gainey Capital ha Azioni in circolazione di 95.196M
- Nano One Materials ha Azioni in circolazione di 95.230M
- Voltalia ha Azioni in circolazione di 95.244M
- Lithoquest Diamonds ha Azioni in circolazione di 95.244M
- Prosperity Bancshares ha Azioni in circolazione di 95.261M